Bioanalytical Community

 View Only
Back to discussions
Expand all | Collapse all

Immunogenicity DIscussion Group Special: Anti drug Antibody Magnitude and Clinical Relevance Using Signal to Noise (S/N): Bococizumab Case Study

  • 1.  Immunogenicity DIscussion Group Special: Anti drug Antibody Magnitude and Clinical Relevance Using Signal to Noise (S/N): Bococizumab Case Study

    Community Leadership
    Posted 10-09-2023 09:48

    Hi All,

    This Wednesday October 11th (12:00 Eastern US, 18:00 Central EU) we will have Dan Baltrukonis and Fred McCush join us to discuss their recent AAPS Journal article 'Anti drug Antibody Magnitude and Clinical Relevance Using Signal to Noise (S/N): Bococizumab Case Study'

    If you and/or members of your team would like to join the discussion, please let me know at [email protected] and I'll get you added.

    Thanks!

    Rob & Todd



    ------------------------------
    Robert Nelson
    Scientific Officer, Senior Director
    BioAgilytix Europe GmbH
    Hamburg Germany
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer or other entities to which I am affiliated.
    ------------------------------